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We conducted surveillance on invasive pneumococci 
isolated from adults in the Czech Republic during 1996–
2003. The 7 most prevalent serotypes were characterized. 
Coverage with the 7-valent pneumococcal conjugate vac-
cine was low. Our observations conﬁ  rm that detection meth-
ods may have modiﬁ  ed the expected effect of this vaccine.
S
treptococcus pneumoniae is a leading cause of illness 
and death in children and adults (1,2). The incidence 
of invasive pneumococcal disease (IPD) has been reduced 
by a 7-valent pneumococcal conjugate vaccine (PCV7) (3). 
Although certain serotypes of S. pneumoniae are recognized 
among children, adults carry a wider range of serotypes (4). 
Several studies have reported cases of IPD in adults caused 
by common childhood serotypes (5,6). The causes of such 
cases are unclear, but use of antimicrobial drugs (6), pro-
gressive population aging (5), and modiﬁ  cations to blood 
culture protocols have been suggested (7). PCV7 efﬁ  cacy 
in children has raised the question of whether to use PCV7 
in elderly persons (5).
In the Czech Republic, patients in follow-up care de-
partments (i.e., <1% of the adult population), have been 
vaccinated with a 23-valent polysaccharide vaccine since 
2001. PCV7 showed a reported 66% serotype coverage in 
children (8) and has been included in the routine childhood 
immunization program since January 2009.
Clones associated with IPD have been characterized by 
genotyping. Use of PCV7 exerts selective pressure against 
vaccine serotypes. Clonality data obtained before vaccine 
use will make it possible to demonstrate future changes in 
the genetic structure of pneumococci. Therefore, the pur-
pose of our study was to identify IPD serotype distribution 
and clonality in adults in the Czech Republic before the use 
of PCV7.
The Study
Invasive pneumococcal isolates from adults >18 
years of age were obtained from blood (n = 460) and cere-
brospinal ﬂ  uid (CSF) (n = 229) during 1996–2003 by 54 
laboratories serving ≈85% of the population in the Czech 
Republic. Isolates were serotyped by using the Quellung 
reaction (9). Antimicrobial drug susceptibility and MICs 
were determined by the broth microdilution method ac-
cording to Clinical and Laboratory Standards Institute 
recommendations (10). Genotyping was performed by 
using pulsed-ﬁ  eld gel electrophoresis (PFGE) (11) and 
multilocus sequence typing (MLST) (12). MLST results 
were identical between isolates of the same serotype 
within a PFGE subtype (13). Cluster analyses were based 
on allelic data that used the eBURST algorithm (14). Nu-
merical trend was evaluated by regression analysis of the 
logarithm of the number of isolates by using SPSS for 
Windows version 14 (SPSS, Inc., Chicago, IL, USA). The 
χ2 test for trend (Epi Info version 3.4; Centers for Disease 
Control and Prevention, Atlanta, GA, USA) was used to 
evaluate variations in proportions of different serotypes; 
p values <0.05 were considered signiﬁ  cant.
During 1996–2003, a total of 446 (64.7%) isolates were 
obtained from adults 18–64 years of age and 243 (35.3%) 
isolates were obtained from adults >65 years of age. A pro-
gressive increase in recovery of isolates from blood was 
observed from 44 during 1996–1997 to 199 during 2002–
2003 (p = 0.009) (Figure 1). Serotyping identiﬁ  ed 48 se-
rotypes; 10 of these serotypes included >30 isolates. Half 
of all strains belonged to serotypes 3 (12.7%), 4 (8.6%), 8 
(7%), 1 (5.8%), 19F (5.5%), 14 (5.5%), and 9V (5.2%) (Fig-
ure 2). Serotype coverage rates by PCV7, PCV10, PCV13, 
and 23-valent polysaccharide vaccine were 32.5%, 44.2%, 
62.3%, and 82.1%, respectively, among adults 18–64 years 
of age and 35.4%, 42.8%, 61.3%, and 85.6%, respectively, 
among adults >65 years of age.
Serotype distribution did not vary signiﬁ  cantly with age 
group and type of isolate, except for serotype 1, which was 
more common (p = 0.037) among younger adults (18–64 
years) and more prevalent in blood (p = 0.004). With the ex-
ception of 1998–1999, serotype 3 was most common iden-
tiﬁ  ed. This serotype, which composed≈11% of all isolates 
during 1996–2001, increased to 15% during 2002–2003 
(p = 0.289). A change was also observed in the propor-
tions of serotypes 1 and 4 (Figure 1). Serotype 1 increased 
from 6% during 1996–1997 to 17% during 1998–1999 
(p = 0.027) and then decreased to 3% during 2002–2003 
(p<0.001). Serotype 4 increased from 2% during 1996–
1997 to 13% during 2002–2003 (p<0.001) (Figure 1).
Penicillin-resistant pneumococci were uncommon 
(range 1%–5%), and no isolate showed high resistance to 
penicillin (MIC >1 mg/L). Resistance to chloramphenicol 
decreased from 5% during 1996–1997 to 2% during 2002–
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DOI: 10.3201/eid1602.0805352003 (p = 0.114). Tetracycline resistance also decreased 
from 8% during 1996–1997 to 6% during 2002–2003 (p = 
0.732). Few (<9) isolates were resistant to erythromycin. 
Antimicrobial drug resistance was associated with certain 
serotypes. Eighteen of 23 penicillin-resistant pneumococci 
isolates belonged to serotype 9V. Resistance to chloram-
phenicol, usually observed with resistance to tetracycline, 
was seen most often in serotype 19F isolates.
Of 347 isolates of the 7 most common serotypes, 335 
were characterized by PFGE and 130 PFGE subtypes were 
analyzed by MLST (online Appendix Table, www.cdc.gov/
EID/content/16/2/287-appT.htm). Forty-six allelic proﬁ  les 
were identiﬁ  ed, 18 of which carried new alleles (n = 11) or 
novel combinations of known alleles (n = 7). Of 10 new 
alleles, 5 belonged to serotype 4. The gdh128 allele was 
identiﬁ  ed in serotype 4 and 9V isolates. Until recently, only 
gdh128 was found among isolates from other countries. At 
least 60% of isolates of serotypes 1, 3, 9V, 14, and 19F 
have been identiﬁ  ed within clones in the Pneumococcal 
Molecular Epidemiology Network. In contrast, only 25% 
of serotype 4 and 8 isolates were identiﬁ  ed in this network, 
and these serotypes consisted of larger clusters unrelated to 
global clones.
Conclusions
When we compared our results with those of a study 
from the United States (5), where 51% of IPD was among 
elderly persons before introduction of PCV7 and caused by 
pediatric serotypes (6B, 9V, 14, 19F, and 23F) (5), our data 
showed a low frequency (27.2%) of pediatric serotypes in 
older adults. The low frequency of penicillin-nonsuscep-
tible pneumococci isolates of pediatric serotypes explains 
the observed predominance of drug-susceptible serotypes. 
Local differences in blood culture protocols could also bias 
the serotype distribution (7). Although the number of blood 
cultures performed in the Czech Republic is increasing, 
lower numbers of invasive pneumococci have been isolated 
than in other countries in Europe (www.rivm.nl/earss).
The observed predominance of serotype 3, previously 
reported as less invasive but associated with a high death 
rate (15), could be explained by sample collection primar-
ily from the most severe IPD cases. In 1998, an increase 
in serotype 1 invasive disease was reported in Sweden. 
In our study, serotype 1 was the most common during the 
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Figure 1. A) Invasive pneumococcal isolates from blood and 
cerebrospinal  ﬂ   uid (CSF) and B) frequency of Streptococcus 
pneumoniae serotypes 1, 3, and 4 among adults, Czech Republic, 
1996–2003.
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Figure 2. Distribution of pneumococcal invasive serotypes among 689 adults, Czech Republic, 1996–2003.Clonal Distribution of Invasive Pneumococci
same period. Subsequently, the frequency of this serotype 
decreased but the frequency of bacteremia increased. The 
gradual increase in bacteremia and increased frequency of 
serotype 4, previously found to be moderately invasive (7), 
could be ascribed to the increase in blood cultures that fa-
cilitated detection of moderate disease caused by serotype 
4 rather than dissemination of a speciﬁ  c invasive clone be-
cause the isolates showed high genotypic diversity. In our 
collection of invasive strains, the frequency of antimicro-
bial drug–resistant global clones, all previously found in 
the Czech Republic (13), varied between serotypes.
Our results support the need for IPD surveillance be-
cause differences in detection methods might modify the 
effect of the vaccine. Continued surveillance will be help-
ful in detecting any shift in the distribution of invasive se-
rotypes and clones circulating in the Czech Republic and in 
monitoring the effect of PCV7 on serotype frequencies and 
the genetic structure of pneumococci.
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